other proteins were expressed using the Dynamite media protocol as described in previously. 6 The resulting cell pellets were stored at -80°C. Frozen cell pellets were thawed and resuspended in 20 mM HEPES, pH 7.3, 300 mM NaCl, 1 mM TCEP, and 1:200 (v/v) protease inhibitor cocktail. KRAS and SOS cat (564-1048) buffers were amended with 5 mM MgCl 2 . Cells were resuspended in 10 ml of buffer per 1000 optical density (OD) units. OD was measured at cell harvest at A 600 . Homogenized cells were lysed by passing twice through a Microfluidizer at 9,000 psi. Lysates were clarified by centrifugation at 7,900 x g (RCF average) for 90 min at 4°C. Clarified lysates were filtered through 0.45 μM Whatman PES syringe filters. All proteins, KRAS (1-169), RAF -RBD (52-131), and SOS cat (564-1048) were purified in a similar manner using NGC medium-pressure chromatography systems. Nucleotide exchange. KRAS (1-169) was exchanged to replace the GDP that is bound to the purified protein with the GTP nonhydrolyzable analog, GMPPNP, essentially as described in previously, with minor exceptions. 4 Specifically, the initial buffer exchange step was omitted. The observed KRAS loading efficiency with GMPPNP was 92%, based on the HPLC analysis.
Quality of the used proteins
Protein quality was analyzed using several methods, not discussed here in details. Shortly, SEC was used to analyze monomeric behavior of the produced proteins, gel electrophoresis (GE) for protein size and purity determination, and mass spectrometry (MS) to find potential modifications and for batch-to-batch variation analysis. SDS-PAGE data for the KRAS and related proteins is presented in Figure S1 , and SEC and SDS-PAGE data for the G(i)α in Figure S2 . 
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Alexa680-RBD and Alexa680-SA preparation
Alexa Fluor 680 NHS Ester was used in streptavidin and RAF-RBD conjugations to prepare SA-Alexa680 and RBD-Alexa680. SA (0.5 mg) and RAF-RBD (0.1 mg) were labeled with two-fold molar excess of Alexa680 in 100 µL or 175 µL, respectively. Light protected three hour SA-Alexa680 and 30 min RBD-Alexa reactions were performed in 50 mM carbonate buffer pH 8.3 (RT). SA-Alexa680 and RBD-Alexa680 conjugates were separated for the free Alexa680-label using 50 mM HEPES (pH 7) and NAP-5 columns according to the manufacturer instructions. The labeling degree for SA-Alexa680 and RBD-Alexa680 were determined based on the monitored absorbance at 280 and 680 nm, and the observed labeling degrees were 1.6 and 1.4, respectively.
γ-GTP-Eu 3+ synthesis
The synthesis of γ-GTP-Eu 3+ in depicted in Figure S3 . GDP (44.3 mg, 0.1 mmol) was dissolved in 10 ml of tert-butanol/water (1:1). Morpholine (44 mg, 0.5 mmol) was added and the solution was then heated to reflux.
DCC (103 mg, 0.5 mmol) dissolved in 10 ml tert-butanol was added to the above refluxing GDP solution. The reaction mixture was kept to reflux for 4 hours and the reaction mixture is then cooled to RT. main peaks using measurement wavelengths of 260 nm (red) and 340 nm (blue). Peaks with the retention times of 2, 7, and 11 min are expected to refer non-labeled γ-GTP, γ-GTP-Eu 3+ , and free Eu 3+ -chelate. The peak observed at the time point of 7 min showed the highest intensity at 340 nm, and it was confirmed to bind Gα. This peak was detected in final purifications and it was used in all Gα assays.
KRAS concentration optimization for dual-parametric detection
KRAS concentration (0-600 nM) was optimized for dual-parametric format using two assay protocols in 15 µL final volume in assay buffer containing 20 mM HEPES (pH 7.5), 1 mM MgCl 2 , 10 mM NaCl, 0.01% Triton X-100, and 0.005% γ-globulins. The first protocol is based on the use of single detection solution and in the second protocol the addition of Eu 3+ -GTP (25 nM) and malachite green (MG, 24 µM) was separated. In both assays, KRAS (4 µL) was added in plate with or without 10 µM GDP (2 µL). The Eu 3+ -GTP was added with (protocol 1, 4 µL) or without (protocol 2, 2 µL) quencher (MG). Signals were
G(i)α loading test with γ-GTP-Eu 3+
Before the enzymatic assay, new synthetized γ-GTP-Eu 3+ (Figure S3 -S5) was tested in GTP titration (0-25 µM) using constant 20 nM G(i)α and six γ-GTP-Eu 3+ (1-50 nM) concentration with individually fixed MT2 concentration (2-4 µM) ( Figure S6 ). G(i)α was first incubated for 30 min in a EDTA containing assay buffer (20 mM HEPES (pH 7.5), 5 mM EDTA, 5 mM NaCl, 0.01% Triton X-100, 0.005% γ-globulins). GTP and γ-GTP-Eu 3+ in complex with MT2 were added in MgCl 2 containing assay buffer (20 mM HEPES (pH 7.5), 20 mM MgCl 2 , 5 mM NaCl, 0.01% Triton X-100, and 0.005% γ-globulins) to reach the final 15 µL volume. TRFsignals at 615 nm were monitored after 30 min.
Data analysis
In all assays, the signal-to-background ratio (S/B) was calculated as µ max /µ min and coefficient of variation 
